Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wagenaar

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Ophthalmic Genetics|December 1, 1995
Ophthalmologic findings in Usher syndrome type 2AA Van Aarem, M Wagenaar, A J Pinckers, et al.
Journal of Molecular Histology|March 16, 2010
Expression patterns of protein C inhibitor in mouse developmentGerry T M Wagenaar, Pavel Uhrin, Klara Weipoltshammer, et al.
American Journal of Medical Genetics|November 20, 1995
Clinical findings in obligate carriers of type I Usher syndromeM Wagenaar, B ter Rahe, A van Aarem, et al.
European Journal of Pharmacology|November 10, 2024
Inhibition of lysophosphatidic acid receptor 2 attenuates neonatal chronic lung disease in mice by preserving vascular and alveolar developmentXueyu Chen, Dongshan Han, Yali Zeng, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 7, 2015
Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory responseXueyu Chen, Frans J Walther, Rozemarijn M A Sengers, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 28, 2011
Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in ratsYvonne P de Visser, Frans J Walther, El Houari Laghmani, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2013
Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injuryGerry T M Wagenaar, El Houari Laghmani, Yvonne P de Visser, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 21, 2016
Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the NetherlandsM Wapenaar, J Twiss, M Wagenaar, et al.
Journal of Clinical Medicine|August 12, 2023
Debridement, Antibiotics and Implant Retention: A Systematic Review of Strategies for Treatment of Early Infections after Revision Total Knee ArthroplastyCaspar W J Hulleman, Tommy S de Windt, Karin Veerman, et al.
Respiratory Research|February 2, 2023
Vascular and pulmonary effects of ibuprofen on neonatal lung developmentXueyu Chen, Dongshan Han, Xuan Wang, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Ophthalmic Genetics|December 1, 1995
Ophthalmologic findings in Usher syndrome type 2AA Van Aarem, M Wagenaar, A J Pinckers, et al.
Journal of Molecular Histology|March 16, 2010
Expression patterns of protein C inhibitor in mouse developmentGerry T M Wagenaar, Pavel Uhrin, Klara Weipoltshammer, et al.
American Journal of Medical Genetics|November 20, 1995
Clinical findings in obligate carriers of type I Usher syndromeM Wagenaar, B ter Rahe, A van Aarem, et al.
European Journal of Pharmacology|November 10, 2024
Inhibition of lysophosphatidic acid receptor 2 attenuates neonatal chronic lung disease in mice by preserving vascular and alveolar developmentXueyu Chen, Dongshan Han, Yali Zeng, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 7, 2015
Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory responseXueyu Chen, Frans J Walther, Rozemarijn M A Sengers, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 28, 2011
Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in ratsYvonne P de Visser, Frans J Walther, El Houari Laghmani, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2013
Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injuryGerry T M Wagenaar, El Houari Laghmani, Yvonne P de Visser, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 21, 2016
Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the NetherlandsM Wapenaar, J Twiss, M Wagenaar, et al.
Journal of Clinical Medicine|August 12, 2023
Debridement, Antibiotics and Implant Retention: A Systematic Review of Strategies for Treatment of Early Infections after Revision Total Knee ArthroplastyCaspar W J Hulleman, Tommy S de Windt, Karin Veerman, et al.
Respiratory Research|February 2, 2023
Vascular and pulmonary effects of ibuprofen on neonatal lung developmentXueyu Chen, Dongshan Han, Xuan Wang, et al.
Pageof 12